Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

Differentiating the Invasiveness of Lung Adenocarcinoma by Dual Energy CT Parameter

Differentiating the Invasiveness of Lung Adenocarcinoma by Dual Energy CT Using Extracellular Volume Measured in Delay Phase

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The core purpose of this study is to investigate whether the extracellular volume (ECV) fraction measured in delay phase by dual energy computed tomography (DECT) can distinguish precancerous lesions from early-stage lung adenocarcinomas, which could assist clinical decision making for surgery operation indication and strategy.

Who May Be Eligible (Plain English)

Who May Qualify: - patients older than 18 years old with pulmonary nodules (diameter≤3 cm). - pathologically confirmed as lung adenocarcinoma. - without history of other malignancies. - accurate hematocrit within 1 week before contrast enhanced dual energy CT examination. Who Should NOT Join This Trial: - with a history of allergy to iodine contrast agents and other reasons who are unable to complete the examination. - without histopathology of invasion stage, such as AAH, AIS, MIA and IAC. - history of chemotherapy, radiotherapy, or other anti-tumor therapy before contrast enhanced dual energy CT. - poor image quality. - contrast enhanced dual energy CT scans ≥ 4 weeks before surgery. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * patients older than 18 years old with pulmonary nodules (diameter≤3 cm). * pathologically confirmed as lung adenocarcinoma. * without history of other malignancies. * accurate hematocrit within 1 week before contrast enhanced dual energy CT examination. Exclusion Criteria: * with a history of allergy to iodine contrast agents and other reasons who are unable to complete the examination. * without histopathology of invasion stage, such as AAH, AIS, MIA and IAC. * history of chemotherapy, radiotherapy, or other anti-tumor therapy before contrast enhanced dual energy CT. * poor image quality. * contrast enhanced dual energy CT scans ≥ 4 weeks before surgery.

Locations (1)

Tangdu Hospital
Xi'an, Shaanxi, China